>>14202271 (lb)
>We tested 68 drugs and compounds and found antiviral activity for several that are FDA approved, in clinical testing, or under preclinical development for various diseases, including silmitasertib (CK2, phase 2), gilteritinib (AXL, FDA approved), ARRY-797 (p38, phase 2/3), MAPK13-IN-1 (p38, preclinical), SB203580 (p38, preclinical), ralimetinib (p38, phase 2), apilimod (PIKFYVE, phase 1), and dinaciclib (CDK, phase 3), among others (Figure S5; Table S8). Silmitasertib, a small molecule undergoing clinical trials for various cancers, is now being considered for testing in humans to combat COVID-19
"If a therapeutic for COVID-19 doesn't move a stock, then it doesn't exist."
Raymond James Investor Newsletter, March 10, 2020
The journal CELL has the highest impact factor of all journals in science. Notice that all the potential therapeutics listed are likely monopolized by Biotech/Big Pharma, will be very expensive (profitable), and are much more likely to be toxic (ROI) than existing generic (eg ivermectin, hydrochloroquine, etc.), OTC drugs or natural plants that can be easily sourced or grown in your back yard.
[They] need to continually prop up the illusion that human disease will progressively become more complicated (& expensive) to treat (never cure).
Our "Medical Nemesis" has become "too big to fail", hence to need to mandate medical intervention world wide once & for all.
If we DO NOT STAND AGAINST this medical fascism now, we will experience another INQUISITION